Cancer of Unknown Primary Site
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18827 | FAPi-46 GA-68 | 1 | Recruiting | 1 |
DB16417 | Geptanolimab | 1 | Completed | 1 |
DB11363 | Alectinib | 2 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB01101 | Capecitabine | 2 | Completed | 1 |
DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
DB05239 | Cobimetinib | 2 | Active Not Recruiting | 1 |
DB11986 | Entrectinib | 2 | Active Not Recruiting | 1 |
DB00530 | Erlotinib | 2 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
DB09257 | Gimeracil | 2 | Completed | 1 |
DB11743 | Ipatasertib | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Unknown Status | 1 |
DB14568 | Ivosidenib | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Unknown Status | 1 |
DB09074 | Olaparib | 2 | Active Not Recruiting | 1 |
DB03209 | Oteracil | 2 | Completed | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB15102 | Pemigatinib | 2 | Active Not Recruiting | 1 |
DB06366 | Pertuzumab | 2 | Active Not Recruiting | 1 |
DB15765 | Sintilimab | 2 | Active Not Recruiting | 1 |
DB09256 | Tegafur | 2 | Completed | 1 |
DB00072 | Trastuzumab | 2 | Active Not Recruiting | 1 |
DB08881 | Vemurafenib | 2 | Active Not Recruiting | 1 |
DB08828 | Vismodegib | 2 | Active Not Recruiting | 1 |